Your account is not claimed yet. You can sign up with ORCID to claim your account.

Samir H Barghout

ResearcherID Scopus Author ID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Venues

Pharmacological reviews

ACS pharmacology & translational science

ACS chemical biology

Leukemia

Princess Margaret Cancer Centre, University Health Nework

University of Toronto (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Princess Margaret Cancer Centre, University Health Nework Apr 15o 2020

Canada

Postdoctoral Fellow

Education History

University of Toronto Sep 1o 2015 - Mar 19o 2020

Canada

PHD :: Molecular Biology Stream, Department of Medical Biophysics

Publications

Safa Majeed, Mansi K Aparnathi, Kevin C J Nixon, Vidhyasagar Venkatasubramanian, Fariha Rahman, Lifang Song, Jessica Weiss, Ranya Barayan, Vijithan Sugumar, Samir H Barghout, Joel D Pearson, Rod Bremner, Aaron D Schimmer, Ming-Sound Tsao, Geoffrey Liu, Benjamin H Lok
Targeting the Ubiquitin-Proteasome System Using the UBA1 Inhibitor TAK-243 is a Potential Therapeutic Strategy for Small-Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (9) (2022)
Francesco Fazzari, Sue Chow, May Cheung, Samir H Barghout, Aaron D Schimmer, Qing Chang, David Hedley
Combined Targeting of the Glutathione and Thioredoxin Antioxidant Systems in Pancreatic Cancer. ACS pharmacology & translational science 5 (11) (2022)
Samir H Barghout, Mandeep K Mann, Ahmed M Aman, Yifan Yu, Matthew G Alteen, Aaron D Schimmer, Matthieu Schapira, Cheryl H Arrowsmith, Dalia Barsyte-Lovejoy
Combinatorial Anticancer Drug Screen Identifies Off-Target Effects of Epigenetic Chemical Probes. ACS chemical biology 17 (10) (2022)
Samir H Barghout, Aaron D Schimmer
E1 Enzymes as Therapeutic Targets in Cancer. Pharmacological reviews 73 (1) (2021)
Samir H Barghout, Parasvi S Patel, Xiaoming Wang, G Wei Xu, Simon Kavanagh, Ondrej Halgas, Sara F Zarabi, Marcela Gronda, Rose Hurren, Danny V Jeyaraju, Neil MacLean, Shawn Brennan, Marc L Hyer, Allison Berger, Tary Traore, Michael Milhollen, Adam C Smith, Mark D Minden, Emil F Pai, Razq Hakem, Aaron D Schimmer
Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia. Leukemia 33 (1) (2018)

Samir H Barghout.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Samir H Barghout